Pulmonary embolism as a first clinical sign of occult malignancy: A prospective follow-up study [1]

Thrombosis and Haemostasis

Volumn 95, Issue 3, 2006, Pages 584-585

  van der Heiden, Pim L J ^a   Prins, Martin H ^b   de Monyé, Wouter ^a   van Strijen, Marco L J ^c   Banga, Jan Dirk ^d   Postmus, Piet E ^e   ten Wolde, Marije ^f   Büller, Harry R ^f   Brandjes, Desiderius P M ^g   Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FISHER EXACT TEST; FOLLOW UP; HUMAN; LETTER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MEDICAL RECORD; OCCULT CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

HUMANS; INCIDENCE; NEOPLASMS; PULMONARY EMBOLISM; TIME FACTORS;

EID: 33645547714     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-10-0667     Document Type: Letter

References (12)

1. Baron JA, Gridley G, Weiderpass E, et al. Venous thromboembolism and cancer. Lancet 1998; 351: 1077-80.
2. Bastounis EA, Karayiannakis AJ, Makri GG, et al. The incidence of occult cancer in patients with deep venous thrombosis: a prospective study. J Intern Med 1996; 239: 153-6.
3. Monreal M, Lafoz E, Casals A, et al. Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer 1991; 67: 541-5.
4. Monreal M, Casals A, Boix J, et al. Occult cancer in patients with acute pulmonary embolism. A prospective study. Chest 1993; 103: 816-9.
5. Prandoni P, Lensing AW, Buller HR, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-33.
6. Sorensen HT, Mellemkjaer L, Steffensen FH, et al. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.
7. Taliani MR, Agnelli G, Prandoni P, et al. Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. J Thromb Haemost 2003; 1: 1730-3.
8. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-63.
9. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-60.
10. van Strijen MJ, Bloem JL, de Monye W, et al. Helical computed tomography and alternative diagnosis in patients with excluded pulmonary embolism. J Thromb Haemost 2005; 3: 2449-56.
11. Prins MH, Lensing AW, Hirsh J. Idiopathic deep venous thrombosis. Is a search for malignant disease justified? Arch Intern Med 1994; 154: 1310-2.
12. Monreal M. Screening for occult cancer in patients with acute venous thromboembolism. J Thromb Haemost 2005; 3: 2389-90.